Описание

Genome features of Bifidobacterium longum subsp. longum 35624 are presented, a probiotic strain with demonstrated clinical efficacy in irritable bowel syndrome trials.

Figure 1

Diagram

Source Paper

Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™.

PloS one (2016)

PMID: 27656878

DOI: 10.1371/journal.pone.0162983

Cite This Figure

![Figure 1: Genome features of Bifidobacterium longum subsp. longum 35624 are presented, a probiotic strain with demonstrated clinical efficacy in irritable bowel syndrome trials.]()

> Source: Friedrich Altmann et al. "Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifido." *PloS one*, 2016. PMID: [27656878](https://pubmed.ncbi.nlm.nih.gov/27656878/)

<figure>
  <img src="" alt="Genome features of Bifidobacterium longum subsp. longum 35624 are presented, a probiotic strain with demonstrated clinical efficacy in irritable bowel syndrome trials." />
  <figcaption>Figure 1. Genome features of Bifidobacterium longum subsp. longum 35624 are presented, a probiotic strain with demonstrated clinical efficacy in irritable bowel syndrome trials.<br>  Source: Friedrich Altmann et al. "Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifido." <em>PloS one</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27656878/">27656878</a></figcaption>
</figure>

Связанные доказательства

Bifidobacterium longum для Irritable Bowel Syndrome (IBS)

Оценка B · 4 исследований